Next Article in Journal
Biological Properties of Fucoxanthin in Oil Recovered from Two Brown Seaweeds Using Supercritical CO2 Extraction
Previous Article in Journal
Construction of Escherichia coli Mutant with Decreased Endotoxic Activity by Modifying Lipid A Structure
Article Menu

Export Article

Open AccessArticle
Mar. Drugs 2015, 13(6), 3407-3421; doi:10.3390/md13063407

The Antihyperlipidemic Mechanism of High Sulfate Content Ulvan in Rats

Weifang Medical University, No.7166 Baotong Road, Weifang 261053, China
*
Author to whom correspondence should be addressed.
Academic Editor: Peer B. Jacobson
Received: 28 March 2015 / Revised: 16 May 2015 / Accepted: 19 May 2015 / Published: 29 May 2015
View Full-Text   |   Download PDF [258 KB, uploaded 29 May 2015]   |  

Abstract

Numerous studies have suggested that hyperlipidemia is closely linked to cardiovascular disease. The aim of this study was to investigate the possible antihyperlipidemia mechanism of HU (high sulfate content of ulvan) in high-cholesterol fed rats. Wistar rats were made hyperlipidemic by feeding with a high-cholesterol diet. HU was administered to these hyperlipidemia rats for 30 days. Lipid levels and the mRNA expressions of FXR, LXR and PPARγ in liver were measured after 30 days of treatment. In the HU-treated groups, the middle dosage group of male rats (total cholesterol (TC): p < 0.01) and the low-dosage group of female rats (TC, LDL-C: p < 0.01) showed stronger activity with respect to antihyperlipidemia. Moreover, some HU groups could upregulate the mRNA expression of FXR and PPARγ and downregulate the expression of LXR. For the male rats, compared with the hyperlipidemia group, the middle dosage HU had the most pronounced effect on increasing the mRNA levels of FXR (p < 0.01); low- and high-dosage HU showed a significant inhibition of the mRNA levels of LXR (p < 0.01). All HU female groups could upregulate the mRNA expression of PPARγ in a concentration-dependent manner. In summary, HU could improve lipid profiles through upregulation of FXR and PPARγ and downregulation of LXR. View Full-Text
Keywords: Ulva pertusa; sulfated polysaccharide; antihyperlipidemic; mechanism Ulva pertusa; sulfated polysaccharide; antihyperlipidemic; mechanism
Figures

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Qi, H.; Sheng, J. The Antihyperlipidemic Mechanism of High Sulfate Content Ulvan in Rats. Mar. Drugs 2015, 13, 3407-3421.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top